- Citations, last 5 years
- 36
- Works, last 5 years
- 9
- h-index
- 91
- Scientists listed
- 2
- Grants since 2016
- 17
Grants received
2025–2026 · research · R44
Accelerating the non-opioid analgesic AFA-281 clinical development with TABA-supported business development
Xinmin Simon Xie · AfaSci (United States) · funded by National Institutes of Health
2023–2025 · cooperative agreement · U43
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
Xinmin Simon Xie · AfaSci (United States) · funded by National Institutes of Health
2023–2025 · cooperative agreement · U43
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
Xinmin Simon Xie · AfaSci (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain
Xinmin Simon Xie · AfaSci (United States) · funded by National Institutes of Health
2023–2025 · research · R43
Developing a novel treatment of cocaine use disorder using an IND dual inhibitor of Cav3 channel and soluble epoxide hydrolase
Xinmin Simon Xie · AfaSci (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain
Xinmin Simon Xie · AfaSci (United States) · funded by National Institutes of Health
2018–2020 · research · R43
Discovering GIRK Channel Direct Activator as a Novel Chronic Insomnia Therapeutic
Xinmin Simon Xie · AfaSci (United States) · funded by National Institutes of Health
2018–2020 · research · R43
Discovering GIRK Channel Direct Activator as a Novel Chronic Insomnia Therapeutic
Xinmin Simon Xie · AfaSci (United States) · funded by National Institutes of Health
2018–2021 · research · R43
Discovering GIRK Channel Direct Activator as a Novel Chronic Insomnia Therapeutic
Xinmin Simon Xie · AfaSci (United States) · funded by National Institutes of Health
2016–2018 · research · R41
Sample-free onsite detection of cocaine using microneedles via laser-treated skin
Mei X Wu · AfaSci (United States) · funded by National Institutes of Health
2016–2018 · research · R43
Developing a novel CGRP antagonist for treatment of dental neuroinflammatory pain
Orapin V Horst · AfaSci (United States) · funded by National Institutes of Health
2015–2021 · research · R44
Development of a Next Generation Visual Performance Assessment System for Rodents
Dong Feng Chen · AfaSci (United States) · funded by National Institutes of Health
2015–2022 · research · R44
Development of a Next Generation Visual Performance Assessment System for Rodents
Dong Feng Chen · AfaSci (United States) · funded by National Institutes of Health
2014–2023 · research · R44
IND-enabling studies on novel Cav3 T-channel modulators for treatment of neuropathic pain
Xinmin Simon Xie · AfaSci (United States) · funded by National Institutes of Health
2014–2021 · research · R44
IND-enabling studies on novel Cav3 T-channel modulators for treatment of neuropathic pain
Xinmin Simon Xie · AfaSci (United States) · funded by National Institutes of Health
2013–2021 · research · R44
Development of patented tricyclic pyrones molecules for the treatment of Alzheimer’s Disease
Xinmin Simon Xie · AfaSci (United States) · funded by National Institutes of Health
2013–2021 · research · R44
Development of patented tricyclic pyrones molecules for the treatment of Alzheimer’s Disease
Xinmin Simon Xie · AfaSci (United States) · funded by National Institutes of Health